ALFA Finder| Revenue growth | 17.3% YoY for FY26. |
|---|---|
| Margins | Consolidated EBITDA margin improved to 22.8% from 20.4%. |
| Demand visibility | Strong hospital occupancy (68-90% in key units). |
| Management confidence | High; tracking toward 25% margin target by FY28. |
Growth
FY26 Consolidated Revenue up 17.3% to ₹9,128 Cr; Hospital revenue grew 19.1%; PAT increased 31.5% to ₹1,064 Cr.
Outlook
Guided 15%+ revenue growth for FY27; 150 bps margin expansion; ₹900 Cr annual capex for 1,800+ bed expansion.
Risks
International business volatility; regulatory drug price caps in Oncology (Punjab/North); intense competition in Bangalore and NCR markets.
Earnings Call filed with NSE, NSE: FORTIS. Summary written with AI assistance from the document.
Fortis Healthcare Ltd: key numbers
- Share price
- ₹771.40
- Market cap
- ₹58,237 Cr
- Revenue (annual)
- ₹9,128 Cr
- Net profit (annual)
- ₹1,042 Cr
- P/E (TTM)
- 56.1×Sector 54.5×
- Promoter holding
- 31.17%+0.00% QoQ
- FII holding
- 23.20%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fortis Healthcare Ltd
All →Fortis Healthcare Investor Presentation: Key Takeaways
Q2FY27 consolidated revenue INR 2,735 Cr (+17.3%), PAT INR 317 Cr (+4.0%, 11.6% margin); H1 revenue INR 5,280 Cr (+17.4%). Net debt/EBITDA 0.87x. Expansion via Suguna acquisition and SLJ Delhi agreement.
Fortis Healthcare Results Update
Fortis Healthcare released a press release on Q2 FY27 results, with consolidated revenue of INR 2,735 Cr up 17.3%. It also disclosed the Suguna Hospital acquisition and a 400+ bed Delhi hospital services agreement.
- hospital beds acquired
- 110.0 beds
Fortis Healthcare Q2 FY27 Results: Net Profit ₹320.5 Cr, Down 2.5% YoY
Fortis Healthcare approved unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026 at its board meeting on November 5, 2026. The filing encloses the results and a limited review report with an emphasis on a SFIO fraud investigation.
- Key figure
- Net profit ₹320.5 Cr · -2.5% YoY
Fortis Healthcare Management Change
Fortis Healthcare's Chief Growth & Innovation Officer, Dr. Ritu Garg, resigned effective close of business on October 31, 2026. The resignation is a senior management personnel change with no monetary impact stated.
Fortis Healthcare Board Meeting Date
Fortis Healthcare will hold a board meeting on 5 November 2026 to approve Q2 and half-year unaudited results and alter terms of ₹1,550 Crore listed NCDs. The filing is a prior intimation of the board meeting with agenda items only.
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr